Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: QORVO BIOTECHNOLOGIES LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-04-02 to 2023-05-31
Current total value of award: $26146139
Description: THE PURPOSE OF THIS MODIFICATION IS TO ADJUST DELIVERABLE DATES, ADD FUNDING FOR NEW MILESTONES, AND EXTEND THE POP OF THE CONTRACT TO PROVIDE A COMBINATION COVID-19 AND FLU MULTIPLEX TEST.